Serum miR-192-5p expression was significantly linked to various hepatitis B virus (HBV) infection marker levels and was identified as a biomarker for pegylated-IFN efficacy in chronic HBV treatment, thereby suggesting its role in HBV replication and antiviral immunity [65]. This evidence concerns the gene IFNA1 and Hepatitis.